. . . . . . . "[p63RhoGEF mRNA and protein level and MYPT-1 phosphorylation status were higher in hypertensive patients and lower in Bartter's/Gitelman's patients compared with healthy individuals: p63RhoGEF mRNA level: 0.59 � 0.17 ??Ct vs. 0.37 � 0.17 vs. 0.20 � 0.19, analysis of variance (ANOVA): P <0.016; p63RhoGEF protein level 1.35 � 0.14 vs. 1.09 � 0.05 vs. 0.90 � 0.09 densitometric units, ANOVA: P <0.0001; MYPT-1: 1.39 � 0.34 vs. 1.01 � 0.12 vs. 0.81 � 0.06, ANOVA: P < 0.0001. p63RhoGEF mRNA was significantly correlated with both SBP and DBP in both hypertensive patients (R = 0.79, P < 0.02 and R = 0.78, P < 0.02) and in Bartter's syndrome/Gitelman's syndrome patients (R = 0.87, P < 0.001 and R = 0.86, P < 0.001), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:57+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .